Proposed Cut Scores for the Nightmare Experience Scale (NExS) Among Nonclinical Samples: An Analog Study
Individual Differences Research December 1, 2023 Emily O. Cooper, William E. Kelly
A scale called the Nightmare Experience Scale (NExS) can accurately identify people who may have clinically salient nightmares, even in a nonclinical sample. In a study of 480 undergraduates, the NExS showed strong ability to distinguish those with possible clinically salient nightmares from controls, with an area under the curve of .941. A cut score of 9 or higher was found to be suitable for detecting potential cases. The findings suggest the NExS is a useful screening tool, but further research with clinical interviews is needed to confirm its value in clinical settings.